NAD+ IV vs NAD+ injections: which delivery is right for you?
NAD+ therapy is delivered two main ways: a slow IV infusion in a recliner, or a quick intramuscular injection. Both put the same molecule into the body, but the experience, the dose, and the evidence differ. Here is how to think about the choice.
October 26, 2026 About 6 min read APRM Solutions Team
What NAD+ therapy is in the first place
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme every cell uses to turn food into energy and to support DNA repair. NAD+ levels decline with age, which is the observation behind the wellness interest in raising them. NAD+ therapy delivers the molecule directly, typically by IV infusion or intramuscular injection, with the goal of supporting energy, recovery, or focus.
How NAD+ IV infusions work
An NAD+ IV infusion runs through an intravenous line over a longer session, usually in a recliner with the medical team nearby. The dose is larger and the delivery is gradual. Some people find the experience relaxing; others feel flushed or nauseated during the infusion, which is one reason supervised delivery matters. Sessions take time to schedule around, often 60 minutes or more.
How NAD+ injections work
An intramuscular injection delivers a smaller dose of NAD+ in a single quick shot, typically into the upper arm or gluteal muscle. It takes minutes rather than an hour, so it is easier to fit into a busy day. The trade-off is dose: the injection route carries less NAD+ at once, and some people find the injection itself more noticeable. Which route suits you depends on your goals, your schedule, and how you tolerate treatment.
What the research does and does not show
The honest summary is that evidence for wellness benefits from either route is still limited. Systematic reviews of NAD+ for anti-aging and wellness have found no eligible clinical outcome trials supporting those specific claims. There are small studies in specific clinical contexts, such as a randomized trial reporting improved heart function after seven days of IV NAD+ in patients with ischemic cardiomyopathy, but a single disease-specific study does not establish general wellness benefits for the IV or the injection route.
The regulatory reality applies to both routes
NAD+ is not FDA-approved to treat any disease, and products used for NAD+ therapy are compounded drugs. The FDA has reminded compounders to use ingredients suitable for sterile compounding, and it has issued recalls of compounded NAD+ products with elevated endotoxin levels. Where your NAD+ comes from and how it is compounded is therefore not a detail to skip; it is reasonable to ask the practice directly.
How to choose between them
This is not a choice to make from a marketing page. A proper consultation reviews your health history, medications, and goals; discusses what is known and unknown about NAD+; and recommends a route, dose, and schedule that fit you, or tells you plainly that NAD+ is not a sensible option. At APRM Solutions, that candidacy evaluation comes before any session, and the team offers both IV and intramuscular delivery based on what is appropriate for each patient.
Starting NAD+ the right way in Shelton, CT
APRM Solutions offers NAD+ by IV and intramuscular injection, always after a candidacy evaluation. Call (475) 314-3113 or arrange a consultation to discuss which delivery fits your goals.
This guide is for education only and is not medical advice. Individual suitability for NAD+ therapy is decided only through an evaluation with a clinician.
Appointments & insurance questions welcome
IV or injection? Let a clinician help you decide
The right delivery depends on your health history and goals. Start with a consultation, not a marketing page.
New and existing patients welcome. Please call to confirm current hours and availability.